[19] Rosenheck, R
Eligibility, Safety Considerations, and Who Should Not Use GLP-1 GLP-1 medications are appropriate for individuals with obesity (BMI 30) or overweight (BMI 2729.9) with weight-related comorbidities, as well as those with type 2 diabetes
Some acrolein-resistant mutants showed reduced glutathione content, suggesting that additional mechanismsindependent of glutathione accumulationmay also confer acrolein resistance
The current patent landscape, however, contains numerous variations on PEG density, chain length, attachment chemistry, and branching architecture that carry later expiration dates
Physical activity helps increase calories burned throughout the day, and activities that strengthen muscles will help prevent weight-loss-related muscle loss, too (more on this below)